Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

HISCREENDIAG

Financiado

Cerrado

Building a Tool to Evaluate and Improve Health Investments in Screening and Diag...

Building a Tool to Evaluate and Improve Health Investments in Screening and Diagnosis of disease Over recent decades, the possibilities for the prevention, diagnosis and treatment of disease have expanded throughout the EU. As a result, health policy decision makers and public funders are faced with the challenge of making ch... ver más

28/02/2011

UGent

473K€

Presupuesto del proyecto: 473K€

Líder del proyecto

UNIVERSITEIT GENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Ver 6 Participantes

Financiación concedida El organismo FP7 notifico la concesión del proyecto el día 2011-02-28 No tenemos la información de la convocatoria

0% 93% 100%

Características del participante

Este proyecto no cuenta con búsquedas de partenariado abiertas en este momento.

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

6 Participantes

UGent

0.00€ | Lider

RIJKSUNIVERSITEIT GRONINGEN

N.D. | Participante

BELSPO

N.D. | Participante

UNIVERSITY OF MANCHESTER

N.D. | Participante

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Líder del proyecto

UNIVERSITEIT GENT No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 473K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Over recent decades, the possibilities for the prevention, diagnosis and treatment of disease have expanded throughout the EU. As a result, health policy decision makers and public funders are faced with the challenge of making choices for health investments to improve the healthy life expectancy of Europeans within the context of constrained resources. Health investments include any new technology for the diagnosis, prevention or treatment of disease. It is not clear to which extent recent decisions on such health investments have been optimal. Public funders sometimes evaluate the impact of health investments, but there is a lack of standardised procedures and criteria. This is even more the case for investments related to screening and diagnosis of disease, and in particular gene technologies. The objectives of this study are: 1. to set up a set of common criteria (a ‘tool’) for the evaluation of health investments related to screening and diagnosis (HISD) in Europe, with a special focus on gene technologies; 2. to guide the better alignment of procedures between all (old and new) MS; and 3. to improve the effectiveness and cost-effectiveness of future HISD. Literature reviews will identify existing methods for evaluating health investments and summarise existing procedures and criteria within member states (MS) for making and evaluating decisions on HISD. In parallel, stakeholders will be invited to participate in a survey allowing a better understanding of the commonalities and differences between MS. Based on this, a draft tool, comprising procedures and criteria for evaluating HISD will be proposed. The draft tool will be assessed by a panel of experts guiding its iterative development. A list of recent HISD in MS will then serve as subject for testing the practical applicability of the tool. Finally, ways for implementing the tool and for the evaluation of HISD in MS will be proposed together with recommendations and political implications at EU level.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores